Filing
Spy
Filing
Spy
Home
About
TGTX
Tg Therapeutics, Inc.
Pharmaceutical preparations (SIC 2834)
CUSIP: 88322Q108
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2020 Q4
11 of 13 quarters
Total Value
$166.57M
Total Shares
3.20M
Net Share Change
-1.19M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$166.57M
3.20M
2.7%
TRIM
-1.19M
(-27.1%)
Maverick Capital
$166.57M
3.20M shares
TRIM
-1.19M
(-27.1%)
TGTX — Tg Therapeutics, Inc. - FilingSpy